Subtype
Muscle Neoplasm
CI-CAN-00001246Explore in graph →
Non-malignant151 active trials1 approved drugs38 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001246Explore in graph →
Clinical trials
760 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06932861 | Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma | not yet recruiting | Early Phase 1 | 5 | Xinxin ZhangOTHER | 0 | Apr 22, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Apr 22, 2025source: clinicaltrials